MFAP4
Microfibril-associated glycoprotein 4
Also known as: MFAP4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55083
- Gene
- MFAP4
- Ensembl
- ENSG00000166482
- Chromosome
- 17
- Canonical length
- 255 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein with similarity to a bovine microfibril-associated protein. The protein has binding specificities for both collagen and carbohydrate. It is thought to be an extracellular matrix protein which is involved in cell adhesion or intercellular interactions. The gene is located within the Smith-Magenis syndrome region. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
255 residues, UniProt reviewed canonical sequence.
>P55083|MFAP4
1 MKALLALPLL LLLSTPPCAP QVSGIRGDAL ERFCLQQPLD CDDIYAQGYQ SDGVYLIYPS
61 GPSVPVPVFC DMTTEGGKWT VFQKRFNGSV SFFRGWNDYK LGFGRADGEY WLGLQNMHLL
121 TLKQKYELRV DLEDFENNTA YAKYADFSIS PNAVSAEEDG YTLFVAGFED GGAGDSLSYH
181 SGQKFSTFDR DQDLFVQNCA ALSSGAFWFR SCHFANLNGF YLGGSHLSYA NGINWAQWKG
241 FYYSLKRTEM KIRRALocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFAP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 1,056 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 1,056 nTPM
- lung: 627 nTPM
- gallbladder: 606 nTPM
- urinary bladder: 457 nTPM
- colon: 283 nTPM
- esophagus: 276 nTPM
Single-cell type
- fibroblasts: 590 nCPM
- decidual stromal cells: 310 nCPM
- smooth muscle cells: 239 nCPM
- hepatic stellate cells: 226 nCPM
- peritubular myoid cells: 207 nCPM
- vascular smooth muscle cells: 165 nCPM
Immune cell
- non-classical monocyte: 1.9 nTPM
- intermediate monocyte: 1.8 nTPM
- eosinophil: 1 nTPM
- classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 20 nTPM
- basal ganglia: 13 nTPM
- midbrain: 12 nTPM
- hypothalamus: 10 nTPM
- cerebral cortex: 9.6 nTPM
- thalamus: 9.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 1.35
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cellular response to UV-B
- elastic fiber assembly
- supramolecular fiber organization
- UV protection
- regulation of collagen metabolic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MFAP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFAP4 as an antibody target. Whether an autoantibody or antibody against MFAP4 could matter depends on whether native MFAP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFAP4 is annotated as secreted, so native MFAP4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MFAP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...